ライフサイエンスコーパス: intranasal administration

1 responses to the Env and Gag proteins after intranasal administration.

2 a 1-microg dose of EtxB was protective after intranasal administration.

3 e GTF peptide vaccines HDS and HDS-GLU after intranasal administration.

4 eafferentation of OB within 3 days following intranasal administration.

5 from lethal influenza virus challenge after intranasal administration.

6 Typhi vaccine strain CVD 908-htrA following intranasal administration.

7 ted delivery of immunogens to NALT following intranasal administration.

8 onotide to the cerebrospinal fluid (CSF) via intranasal administration.

9 mes was detected in PD mouse brain following intranasal administration.

10 ronchoconstriction in vivo model in mice via intranasal administration.

11 e and cause disease in BALB/c mice following intranasal administration.

12 uroprotection by PcTX was also achievable by intranasal administration.

13 um concentration (Tmax) in CSF was less upon intranasal administration (15min) compared to i.v. admin

14 d avoid potential contraindications based on intranasal administration alone and provide opportunitie

15 eficient mice were infected with H1N1 PR8 by intranasal administration and course of influenza pneumo

16 ested in influenza-infected mice by oral and intranasal administration and found to be very effective

17 mits VSV replication in the mouse lung after intranasal administration and reduces virus spread to ot

18 etrated pulmonary epithelial cells following intranasal administration, and nocardiae were recovered

19 tokine responses to allergens, while in vivo intranasal administration at very low doses led to local

20 Intranasal administration avoids first-pass metabolism a

21 At 6 h, and up to 48 h after intranasal administration, beads were observed as intrac

22 These results suggest that intranasal administration could be a potential noninvasi

23 ld increase in skin SNA during the period of intranasal administration followed by a sustained 2.4-fo

24 or, accumulates in cerebrospinal fluid after intranasal administration in macaques and humans and mod

25 ibroblasts from pediatric patients and after intranasal administration in mice.

26 Mucosal (intranasal) administration in mice of the purified chime

27 Likewise, nCB intranasal administration induced emphysema in mouse lun

28 ritoneal, or intranasal immunization routes, intranasal administration induced the strongest protecti

29 mice had a similar course of infection after intranasal administration of 16M, validating the usefuln

30 in Stat6-/- mice were targeted via the daily intranasal administration of 200 ng of IL-13-PE38QQR (IL

31 emotion classification task 45 minutes after intranasal administration of 26 IU of oxytocin or placeb

32 Intranasal administration of 6 potently inhibits feeding

33 morbidly obese patients and the finding that intranasal administration of a fragment of melanocortin

34 Intranasal administration of a Gag-Fc/CpG vaccine protec

35 d BALB/c mice compared to controls following intranasal administration of a lethal dose of B. dermati

36 munization regimens that involved an initial intranasal administration of a live influenza virus vect

37 in airway epithelial cells and myocytes, and intranasal administration of a PAR2 agonist stimulated m

38 In both mice and ferrets, intranasal administration of a single dose of the eq/GA/

39 ed by the internal gene segments from AA ca. Intranasal administration of a single dose of the three

40 In conclusion, we show that intranasal administration of AAV vectors results in effi

41 We demonstrated that intranasal administration of adeno-UGRP1 successfully de

42 Intranasal administration of adenovirus expressing IL-17

43 Overall, our data show that intranasal administration of Ag with NE induces TLR2 and

44 Therefore, this study compared intranasal administration of AgNPs versus soluble silver

45 Intranasal administration of AGPs induced intrapulmonary

46 Intranasal administration of allergen induced rises of a

47 Intranasal administration of Alternaria challenge reduce

48 Similarly, intranasal administration of an AAV2/5-CC10-factor IX ve

49 lthy participants and studied the effects of intranasal administration of an arginine vasopressin 1A

50 Intranasal administration of an El Tor O1 V. cholerae st

51 A single intranasal administration of an eukaryotic expression ve

52 nduced in DBA/1 mice and monitored following intranasal administration of an IL-10 plasmid (pG-IL-10)

53 The intranasal administration of an IL-13 immunotoxin chimer

54 nst an airborne challenge with P. carinii by intranasal administration of antibody.

55 Intranasal administration of antigen into c-Kit-mutant m

56 ations, the effect of either subcutaneous or intranasal administration of B-(9-23) on the incidence o

57 ted here indicate that both subcutaneous and intranasal administration of B-(9-23) resulted in a mark

58 th infection in normal C57BL/6 animals after intranasal administration of B. melitensis 16M.

59 This study tested the hypothesis that intranasal administration of BCG with cholera toxin (CT)

60 In addition, intranasal administration of beta-toxin evoked the chara

61 A single intranasal administration of BHPIV3 expressing the SARS-

62 In addition, by using intranasal administration of BrdU during infection, we o

63 Intranasal administration of CCL2, IFN-gamma, or CXCL9 w

64 Local, intrapulmonary blockade of CD49d by intranasal administration of CD49d mAb inhibited all sig

65 Intranasal administration of CDG did not induce TNF-alph

66 Intranasal administration of CLH001 to BALB/c and NOD SC

67 pletion of recovered alveolar macrophages by intranasal administration of clodronate-containing lipos

68 In a pilot experimental colds study, intranasal administration of CP buffer, compared with no

69 The data establish that intranasal administration of CpG ODN 1 day prior to leth

70 in A (IgA) responses were not detected after intranasal administration of diepitopic HDS-GLU peptide

71 Rats were exposed to intranasal administration of E-selectin every other day

72 We report that intranasal administration of either fibroblast growth fa

73 Here we explored the effects of intranasal administration of exogenous recombinant human

74 More important, replenishment of Sema3E by intranasal administration of exogenous Sema3E protects m

75 We observed that a single intranasal administration of GAD65 peptides to 2-3-wk-ol

76 mmation was subsequently induced by means of intranasal administration of house dust mite (HDM) extra

77 Intranasal administration of IFN-gamma to mice after IL-

78 Intranasal administration of IL-12 to mice nasally immun

79 sive cells in the lung were targeted via the intranasal administration of IL-13-PE38QQR (IL-13-PE), c

80 Intranasal administration of IL-17 revealed a crucial ro

81 Moreover, intranasal administration of Il-1beta promoted clearance

82 Intranasal administration of IL-25 into naive mice induc

83 Intranasal administration of IL-25 or IL-33 induced IL-1

84 In contrast, intranasal administration of IL-25-expressing adenovirus

85 RB KO and IL-17RA KO mice did not respond to intranasal administration of IL-25.

86 Intranasal administration of IL-33 to wild-type mice ind

87 In wild-type mice, intranasal administration of IL-37 ablated allergic airw

88 Similarly, intranasal administration of IL-4 enhanced bacterial cle

89 Intranasal administration of IL-5 caused eosinophil migr

90 Intranasal administration of IL-5 caused eosinophil migr

91 Furthermore, intranasal administration of IL-5 restored the impairmen

92 rotection in the lung could be stimulated by intranasal administration of inactivated LVS together wi

93 n be protected against rotavirus shedding by intranasal administration of individual rotavirus protei

94 8 T cells using anti-CD8 Ab treatment before intranasal administration of infectious RSV.

95 All volunteers underwent intranasal administration of influenza A/Wisconsin/67/20

96 A single intranasal administration of influenza hemagglutinin or

97 Here, we treated mice with daily intranasal administration of insulin (1.75 U/day) for on

98 ese findings show a therapeutic potential of intranasal administration of insulin before surgery to r

99 subtype and was fully blocked through daily intranasal administration of interferon to either inocul

100 using mouse embryonic lung organ culture and intranasal administration of interleukin (IL) 10 reveale

101 The effect of intranasal administration of keratinocyte growth factor

102 In mice, intranasal administration of leptin produced elevated br

103 Mice received unilateral intranasal administration of lipopolysaccharide (LPS) or

104 to promote this infection, we depleted AM by intranasal administration of liposome-encapsulated clodr

105 A single intranasal administration of live attenuated vaccine wit

106 Intranasal administration of low dosage (<1.2 mumol/kg/d

107 a model of acute lung injury established by intranasal administration of LPS to mice.

108 Intranasal administration of LTC4 to OVA-sensitized C57B

109 To investigate the effect of intranasal administration of major birch pollen allergen

110 reduce the level of protection stimulated by intranasal administration of MBP::VP6.

111 Similarly, intranasal administration of MOG(35-55) before EAE induc

112 el of temporal lobe epilepsy to determine if intranasal administration of nanoparticles containing TR

113 Intranasal administration of neutralizing anti-IL-12 at

114 The results show that intranasal administration of non-pregnant sheep with a l

115 ses of allergen-specific IgE levels, whereas intranasal administration of omalizumab did not enhance

116 We have shown that prophylactic intranasal administration of our lead fusion inhibitor e

117 Intranasal administration of OVA induced an initial phas

118 ovide the first behavioral evidence that the intranasal administration of OXT stimulates men in a mon

119 Following intranasal administration of oxytocin (OT), we measured,

120 Intranasal administration of oxytocin (vs placebo) incre

121 Thus, intranasal administration of oxytocin reduced stress eff

122 s who completed the trial showed that 6-week intranasal administration of oxytocin significantly redu

123 Importantly, intranasal administration of P4 at an early stage of inf

124 Intranasal administration of papain stimulated ILC2s and

125 la response to fearful faces following acute intranasal administration of PBO or OXT.

126 These results show that intranasal administration of PspA together with mCT S61F

127 ylated AM G proteins both in vitro and after intranasal administration of PT in mice and that the dur

128 Additionally, we showed that intranasal administration of PT inhibits lipopolysacchar

129 tly outcompeted by the wild-type strain, and intranasal administration of purified ACT did not increa

130 ensitized fB-/- mice could be restored after intranasal administration of purified factor B before th

131 Intranasal administration of purified PT up to 14 days p

132 Biodistribution studies following intranasal administration of radiolabeled peptide demons

133 mococcal disease in TLR4-defective mice, the intranasal administration of rBPI21 following intranasal

134 ent and bacterial clearance were restored by intranasal administration of recombinant CXCL5.

135 Furthermore, intranasal administration of recombinant mindin signific

136 with vancomycin or streptomycin by repeated intranasal administration of Saccharopolyspora rectivirg

137 Systemic or intranasal administration of salmeterol protected agains

138 Treatment with the SOD mimetic MnTBAP and intranasal administration of SOD-containing polyketal mi

139 did not generate an anti-B5 immune response, intranasal administration of soluble pB5 led to a rise o

140 Repetitive intranasal administration of soluble peptide induces per

141 Intranasal administration of SPEA induced airway inflamm

142 Human imaging studies have revealed that intranasal administration of the "prosocial" hormone oxy

143 Intranasal administration of the combined LOS conjugates

144 against MPXV disease was demonstrated by the intranasal administration of the mouse cytokine to CAST/

145 Intranasal administration of the mucus penetrating DNA n

146 Because the intranasal administration of the neuropeptide oxytocin h

147 Thus, a single intranasal administration of the poxvirus modified vacci

148 A single intranasal administration of the Salmonella clones to mi

149 The current study evaluated whether intranasal administration of the sialic acid analog 4-gu

150 In contrast, repeated intranasal administration of the specific peptide result

151 Intranasal administration of these peptides results in p

152 ceived focus in numerous studies associating intranasal administration of this peptide with various a

153 In initial studies, we showed that intranasal administration of this plasmid (along with Do

154 After a single intranasal administration of this vector, secretion of E

155 Ag alone, we treated OVA-immunized mice with intranasal administration of trinitrophenyl-OVA or trini

156 Here we show that intranasal administration of virus-like particles (VLPs)

157 Whereas, intranasal administration of ziconotide in the form of i

158 formation in gene therapy by prior mucosal (intranasal) administration of a peptide representing a h

159 ment 1 (244 DI virus) and shown earlier that intranasal administration protects mice from lethal dise

160 Intranasal administration provides a non-invasive drug d

161 In addition, intranasal administration showed the capacity to induce

162 Following intranasal administration, the model paramyxovirus simia

163 Following intranasal administration, the severe acute respiratory

164 Following intranasal administration, the virus replicated in the l

165 bacter jejuni infection of mice initiated by intranasal administration was investigated as a potentia

166 g-specific siRNA delivery can be achieved by intranasal administration without the need for viral vec